Who owns TRAVERE THERAPEUTICS INC (TVTX?
- CUSIP Number: 89422gaa5
Tip: Access positions for across all investors
Analyze quarterly positions in Travere Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Travere Therapeutics stock
Who bought or sold TRAVERE THERAPEUTICS INC (TVTX this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | ||
|---|---|---|---|---|---|---|
| Capstone Investment Advisors | 48M | $44M | 38% | Dec 2022 | ||
| D. E. Shaw & Co | 38M | $35M | 32% | Dec 2022 | ||
| Wolverine Asset Management | 38M | $35M | 0% | Dec 2022 | ||
| Lazard Asset Management | 32M | $29M | 8% | Dec 2022 | ||
| Braidwell | 31M | $29M | 100% | Dec 2022 | ||
| Polar Securities | 30M | $27M | 0% | Dec 2022 | ||
| Citigroup | 15M | $14M | 0% | Dec 2022 | ||
| Aviva | 15M | $14M | 0% | Dec 2022 | ||
| Highbridge Capital Management | 10M | $9.2M | -47% | Dec 2022 | ||
| Readystate Asset Management | 9.0M | $8.2M | 100% | Dec 2022 | ||
| Leucadia National Corporation | 7.8M | $7.1M | 100% | Dec 2022 | ||
Setup an alertWant to be notified whenever an investor makes a significant change to their holdings of Travere Therapeutics? |
||||||
| Segantii Capital Management | 7.3M | $6.7M | 100% | Dec 2022 | ||
| CSS | 5.2M | $4.7M | 100% | Dec 2022 | ||
| III Capital Management | 4.2M | $3.8M | 100% | Dec 2022 | ||
| Absolute Investment Advisers | 4.0M | $3.7B | 0% | Dec 2022 | ||
| BlackRock | 3.2M | $2.9M | -81% | Dec 2022 | ||
| Laurion Capital Management | 1.5M | $1.4M | 0% | Dec 2022 | ||
| Jane Street | 1.4M | $1.3M | 533% | Dec 2022 | ||
| Nomura Holdings | 615k | $129k | 14% | Dec 2022 | ||
| Caas Capital Management | 500k | $454k | 0% | Dec 2022 | ||
| Jefferies Group | 25k | $26k | -99% | Sep 2022 | ||
| Context Capital Management | 23k | $21M | 363% | Dec 2022 | ||
| Pura Vida Investments | 5.0k | $458k | 0% | Dec 2022 | ||
| Boussard & Gavaudan Investment Management | 3.8k | $3.5M | 0% | Dec 2022 | ||
| Natixis | 2.5k | $53k | 0% | Dec 2022 | ||
Who sold out of Travere Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Perceptive Advisors | Sep 2022 | 45M | $46M |
| SSI Investment Management | Sep 2022 | 6.3M | $6.5M |
| Point72 Asset Management | Sep 2022 | 4.0M | $4.1M |
| Advent Capital Management | Sep 2022 | 1.5M | $1.5M |
| Kornitzer Capital Management | Sep 2022 | 500k | $509k |
| First Hawaiian Bank | Sep 2022 | 129k | $131k |
| SG Americas Securities | Sep 2022 | 11k | $1.1M |